Atlas Trials

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

Clinical trial NCT07136987 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07136987
Sponsor
Open Source Pharma Foundation
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Tuberculosis
Start date
2026-01-01
Primary completion
2031-01-01
Enrollment
1104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.